Wolverine Asset Management »

Astria Therapeutics shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Astria Therapeutics shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3k 100 13.09

More positions owned by Wolverine Asset Management

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Iren Ordinary Shares Put Option (IREN)
Boeing Company Call Option (BA)
Rivian Automotive Com Cl A Call Option (RIVN)
Rocket Lab Corp Put Option (RKLB)
Apple Call Option (AAPL)
Lucid Group Com New Put Option (LCID)
Strategy Cl A New Call Option (MSTR)
Ast Spacemobile Com Cl A Put Option (ASTS)
NVIDIA Corporation Call Option (NVDA)
Bloom Energy Corp Com Cl A Call Option (BE)
Strategy Note 0.625% 9/1 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Meta Platforms Cl A Call Option (META)
Trip Com Group Note 0.750% 6/1 (Principal)

View all positions for Wolverine Asset Management

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics